Facebook Linkedin Twitter
Inside Precision Medicine Bayer and NextRNA Sign $500M+ IncRNA Oncology Deal 

Non-coding RNA

ribonicleic acid chain from which can be used to make RNA silencing treatments for conditions such as congenital melanocytic nevus syndrome
News & Features

Bayer and NextRNA Sign $500M+ IncRNA Oncology Deal 

0
Systemic lupus erythematosus (SLE) positive
News & Features

Reason Underlying Female-Based Autoimmunity Revealed

0
Illustration of the prostate organ in blue surrounded by red cancer cells to symbolize prostate cancer
News & Features

Minor Spliceosome Inhibition Using siRNA Results in Prostate Cancer Cell Death

0
Cancer Gene
Molecular Dx

Non-Coding RNA Provides Window on Disease

0
Pancreas
News & Features

Biomarkers ID Risk of Pancreatic Cysts Developing into Cancer

0
DNA Modification
Molecular Dx

Non-Coding RNA Related to KRAS Could Aid Early Cancer Diagnosis

0
Researchers Highlight Need to Test for Noncoding Variants in Rare Disease Diagnosis
Molecular Dx

Researchers Highlight Need to Test for Noncoding Variants in Rare Disease Diagnosis

0
Cancer cells on dna stand background. 3d illustration
Molecular Dx

RNA Can Control DNA Repair in Cancer Cells

0
PD-1 Antibody Targeting Immune Checkpoint Inhibitor
News & Features

Germline Mutations Predict Toxicity to Checkpoint Inhibitors

Alice McCarthy
0
Illustration of DNA helices undergoing gene or base editing on a blue background
Molecular Dx

Gene-Silencing Tool Could Help Develop Better Therapeutics for Genetic Disease

0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine